{"schema_version":"bookimed.page-context.v1","id":"doctor-samir-kapadia","url":"https://hub.bookimed.com/heart-surgery/doctor-samir-kapadia/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/doctor-samir-kapadia.json","index_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/index.json","full_dataset_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/content.json","content_revision":"source-driven-rankings-20261008","date_modified":"2026-10-08","language":"en","kind":"doctor-profile","title":"Samir Kapadia: TAVR and interventional cardiology","summary":"Samir Kapadia is a Cleveland Clinic interventional cardiologist whose practice includes TAVR and other percutaneous valve treatments. His role is catheter therapy within a heart team; surgical valve replacement is performed by a cardiac surgeon.","research_credit":{"name":"Yevhenii Kozlov","role":"Co-Founder of Bookimed","url":"https://us-uk.bookimed.com/ceo/kozlov/","contribution":"Research personally prepared and reviewed","assistance":"AI tools assisted source research."},"editorial_scope":"Source-based patient information; an individual treatment plan requires clinical review.","research_method":"How this guide is researched and compared Research project led by Yevhenii Kozlov . We link clinical guidance, primary studies and named hospital or offer sources beside the relevant statements. Comparisons distinguish individual operators from programme results and preserve the study population, follow-up and limitations. Prices are dated examples with their stated scope. Research and editorial preparation are separate from clinical review; no named clinician has medically reviewed this edition. Bookimed provides care coordination. Partner and reference programmes are identified from their sources; paid ordering is not used in our published-cohort comparison. Read the editorial policy .","key_takeaways":[{"label":"A catheter specialist","text":"His official profile names TAVR, percutaneous valve therapies and complex coronary interventions.","sources":["pd-adult-kapadia-official"]},{"label":"Seven-year randomized comparison","text":"PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis and found no significant difference in its two primary composites at seven years.","sources":["pd-adult-partner3"]},{"label":"Durability remains time-bounded","text":"The trial reported bioprosthetic valve failure of 6.9% after TAVR and 7.5% after surgery at seven years, not lifetime durability.","sources":["pd-adult-partner3"]}],"benefits":[{"text":"His clinical scope provides a catheter-based aortic-valve pathway with seven-year randomized evidence available for selected low-risk patients.","sources":["pd-adult-kapadia-official","pd-adult-partner3"]}],"limitations":[{"text":"Kapadia coauthored a multicentre, industry-funded study of a particular valve platform. These trial results are not his personal outcomes and do not cover every aortic anatomy.","sources":["pd-adult-kapadia-official","pd-adult-partner3"]}],"sections":[{"id":"benefit-balance","title":"Benefits and limitations","text":"Benefits and limitations Potential advantages His clinical scope provides a catheter-based aortic-valve pathway with seven-year randomized evidence available for selected low-risk patients. Sources: Samir Kapadia, MD · Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. Trade-offs and limits Kapadia coauthored a multicentre, industry-funded study of a particular valve platform. These trial results are not his personal outcomes and do not cover every aortic anatomy. Sources: Samir Kapadia, MD · Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","links":[{"label":"Samir Kapadia, MD","url":"https://my.clevelandclinic.org/staff/5003-samir-kapadia"},{"label":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/"},{"label":"Samir Kapadia, MD","url":"https://my.clevelandclinic.org/staff/5003-samir-kapadia"},{"label":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/"}]},{"id":"research","title":"Procedure-specific research","text":"Procedure-specific research Seven-year randomized comparison of TAVR and surgery PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis. At seven years the report found no significant difference in its two primary composite endpoints involving death, stroke and rehospitalization. How to interpret this: Selected trial population and a particular transcatheter platform; industry funded. It does not establish lifetime durability, suitability for every anatomy, or Kapadia-specific complication rates. Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","links":[{"label":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/"}]},{"id":"team","title":"Clinical programme","text":"Clinical programme Cleveland Clinic → Cleveland, Ohio, United States Cleveland’s cardiac services bring together different expertise: Gillinov’s mitral/robotic work, Smedira’s myectomy practice, Kapadia’s catheter valve treatment and Unai’s endocarditis and redo reconstruction. Its published cohorts show why valve anatomy and supporting tissues can matter as much as the incision. Sources: Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center · Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases · Samir Kapadia, MD · Shinya Unai, MD — cardiac surgery profile · Mitral and Tricuspid Valve Center · Robotically Assisted Mitral Valve Repair: Patient Applications Grow · Nicholas Smedira — current clinical profile · Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. · The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathologic Challenges. · Mitral valve abscess: echocardiographic imaging, microbiology, management, and outcomes. Explore the programme and other specialists →","links":[{"label":"Cleveland Clinic →","url":"https://hub.bookimed.com/heart-surgery/clinic-cleveland/"},{"label":"Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center","url":"https://doi.org/10.1016/j.jtcvs.2018.11.148"},{"label":"Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases","url":"https://pubmed.ncbi.nlm.nih.gov/28893396/"},{"label":"Samir Kapadia, MD","url":"https://my.clevelandclinic.org/staff/5003-samir-kapadia"},{"label":"Shinya Unai, MD — cardiac surgery profile","url":"https://providers.clevelandclinic.org/provider/shinya-unai/4268207"},{"label":"Mitral and Tricuspid Valve Center","url":"https://my.clevelandclinic.org/departments/heart/depts/mitral-and-tricuspid-valve-center"},{"label":"Robotically Assisted Mitral Valve Repair: Patient Applications Grow","url":"https://consultqd.clevelandclinic.org/robotically-assisted-mitral-valve-repair-patient-applications-grow"},{"label":"Nicholas Smedira — current clinical profile","url":"https://providers.clevelandclinic.org/provider/nicholas-smedira/4268212"},{"label":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/"},{"label":"The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathologic Challenges.","url":"https://pubmed.ncbi.nlm.nih.gov/41482022/"},{"label":"Mitral valve abscess: echocardiographic imaging, microbiology, management, and outcomes.","url":"https://pubmed.ncbi.nlm.nih.gov/42394651/"},{"label":"Explore the programme and other specialists →","url":"https://hub.bookimed.com/heart-surgery/clinic-cleveland/"}]}],"introduction":"Heart surgery guide / Samir Kapadia Samir Kapadia · Decision guide Samir Kapadia: TAVR and interventional cardiology Catheter aortic-valve treatment with seven-year trial evidence · Cleveland, Ohio, United States Research by Yevhenii Kozlov · Co-Founder of Bookimed Updated 8 October 2026 Sources linked throughout At a glance Samir Kapadia is a Cleveland Clinic interventional cardiologist whose practice includes TAVR and other percutaneous valve treatments. His role is catheter therapy within a heart team; surgical valve replacement is performed by a cardiac surgeon. A catheter specialist His official profile names TAVR, percutaneous valve therapies and complex coronary interventions. Sources: Samir Kapadia, MD Seven-year randomized comparison PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis and found no significant difference in its two primary composites at seven years. Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. Durability remains time-bounded The trial reported bioprosthetic valve failure of 6.9% after TAVR and 7.5% after surgery at seven years, not lifetime durability. Sources: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. Portrait source ↗ interventional cardiologist Samir Kapadia Cleveland Clinic → Interventional cardiologist; Chair, Department of Cardiovascular Medicine Interventional cardiologist; Chair, Department of Cardiovascular Medicine · Cleveland, Ohio, United States. Read the clinical or research source ↗","related_documents":[{"id":"heart-surgery","title":"Heart surgery abroad: treatments, clinics and costs","kind":"home","url":"https://hub.bookimed.com/heart-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-surgery.json"},{"id":"heart-valve-surgery","title":"Heart valve surgery: repair, replacement and catheter options","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/heart-valve-surgery/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/heart-valve-surgery.json"},{"id":"surgeons","title":"Find cardiac surgeons and heart specialists by procedure","kind":"surgeons","url":"https://hub.bookimed.com/heart-surgery/surgeons/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/surgeons.json"},{"id":"surgeon-rankings","title":"Heart surgeon rankings by reported experience, method and results","kind":"guide","url":"https://hub.bookimed.com/heart-surgery/surgeon-rankings/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/surgeon-rankings.json"},{"id":"clinic-cleveland","title":"Cleveland Clinic: heart surgery expertise","kind":"clinic-profile","url":"https://hub.bookimed.com/heart-surgery/clinic-cleveland/","json_url":"https://hub.bookimed.com/wp-content/uploads/heart-surgery-hub-20261007/pages/clinic-cleveland.json"}],"entity":{"id":"samir-kapadia","name":"Samir Kapadia","programme_id":"cleveland","role":"Interventional cardiologist; Chair, Department of Cardiovascular Medicine","procedure_relevance":["Transcatheter aortic valve replacement (TAVI/TAVR), structural valve interventions and complex coronary intervention."],"source_ids":["pd-adult-kapadia-official","pd-adult-partner3"],"official_url":"https://my.clevelandclinic.org/staff/5003-samir-kapadia","discipline":"interventional cardiologist","topic_slugs":["aortic-valve-disease","tavi-vs-surgical-valve-replacement","heart-valve-surgery"],"profile":{"intro":"Samir Kapadia is a Cleveland Clinic interventional cardiologist whose practice includes TAVR and other percutaneous valve treatments. His role is catheter therapy within a heart team; surgical valve replacement is performed by a cardiac surgeon.","clinical_focus":[{"label":"A catheter specialist","text":"His official profile names TAVR, percutaneous valve therapies and complex coronary interventions.","source_ids":["pd-adult-kapadia-official"]},{"label":"Seven-year randomized comparison","text":"PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis and found no significant difference in its two primary composites at seven years.","source_ids":["pd-adult-partner3"]},{"label":"Durability remains time-bounded","text":"The trial reported bioprosthetic valve failure of 6.9% after TAVR and 7.5% after surgery at seven years, not lifetime durability.","source_ids":["pd-adult-partner3"]}],"evidence":[{"title":"Seven-year randomized comparison of TAVR and surgery","summary":"PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis. At seven years the report found no significant difference in its two primary composite endpoints involving death, stroke and rehospitalization.","limitations":"Selected trial population and a particular transcatheter platform; industry funded. It does not establish lifetime durability, suitability for every anatomy, or Kapadia-specific complication rates.","source_ids":["pd-adult-partner3"]}],"consultation_questions":[],"current_role_note":"Interventional cardiologist; Chair, Department of Cardiovascular Medicine · Cleveland, Ohio, United States.","key_takeaways":[{"label":"A catheter specialist","text":"His official profile names TAVR, percutaneous valve therapies and complex coronary interventions.","sources":["pd-adult-kapadia-official"]},{"label":"Seven-year randomized comparison","text":"PARTNER 3 randomized 1,000 low-risk patients with severe symptomatic aortic stenosis and found no significant difference in its two primary composites at seven years.","sources":["pd-adult-partner3"]},{"label":"Durability remains time-bounded","text":"The trial reported bioprosthetic valve failure of 6.9% after TAVR and 7.5% after surgery at seven years, not lifetime durability.","sources":["pd-adult-partner3"]}],"benefits":[{"text":"His clinical scope provides a catheter-based aortic-valve pathway with seven-year randomized evidence available for selected low-risk patients.","sources":["pd-adult-kapadia-official","pd-adult-partner3"]}],"limitations":[{"text":"Kapadia coauthored a multicentre, industry-funded study of a particular valve platform. These trial results are not his personal outcomes and do not cover every aortic anatomy.","sources":["pd-adult-kapadia-official","pd-adult-partner3"]}],"patient_sections":[{"id":"benefit-balance","title":"Benefits and limitations","paragraphs":[],"items":[],"sources":[],"kind":"benefit-balance","links":[],"table":null},{"id":"research","title":"Procedure-specific research","paragraphs":[],"items":[],"sources":[],"kind":"doctor-evidence","links":[],"table":null},{"id":"team","title":"Clinical programme","paragraphs":[],"items":[],"sources":[],"kind":"doctor-clinic","links":[],"table":null}]},"photo_candidate":{"url":"https://assets.clevelandclinic.org/transform/68f1f4b8-c44d-49e4-a1f2-c430bad29228/samir-r-kapadia-md","source_page":"https://my.clevelandclinic.org/staff/5003-samir-kapadia","alt":"Portrait of Samir Kapadia","source_alt":"Samir Kapadia","provenance":"URL observed on official page; image bytes not downloaded; coordinator to inspect before use."},"topics":["valve"],"headline":"TAVR and interventional cardiology","profile_slug":"doctor-samir-kapadia","portrait":{"url":"https://hub.bookimed.com/wp-content/uploads/2026/10/samir-kapadia-240x300.jpg","source_page":"https://my.clevelandclinic.org/staff/5003-samir-kapadia","width":1200,"height":1500,"alt":"Portrait of Samir Kapadia"}},"sources":{"cleveland-programme":{"id":"cleveland-programme","title":"Mitral and Tricuspid Valve Center | Cleveland Clinic","url":"https://my.clevelandclinic.org/departments/heart/depts/mitral-and-tricuspid-valve-center","read_at":"2026-10-07","source_type":"official_hospital"},"rank-cleveland1559":{"id":"rank-cleveland1559","title":"Surgical management of LVOT obstruction in a specialized HOCM center","url":"https://doi.org/10.1016/j.jtcvs.2018.11.148","read_at":"2026-10-07","source_kind":"primary_study","body_access":"primary_abstract_read_full_text_subscription","support_location":"PubMed30782406; Methods/Results","short_excerpt":"1559 consecutive operations for left ventricular outflow tract obstruction","source_type":"primary_study"},"rank-smedira-current":{"id":"rank-smedira-current","title":"Nicholas Smedira, MD — Cleveland Clinic","url":"https://providers.clevelandclinic.org/provider/nicholas-smedira/4268212","read_at":"2026-10-07","source_kind":"official_hospital_profile","body_access":"full_page_read","support_location":"Biography; Specialty interests; Number of Procedures Performed; Locations","short_excerpt":"including 350 heart transplants and more than 2,000 septal myectomies","source_type":"official_hospital_profile"},"mitral-cleveland-robotic-learning-0":{"url":"https://pubmed.ncbi.nlm.nih.gov/28893396/","doi":"10.1016/j.jtcvs.2017.07.037","title":"Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases","published":"2018 issue; 2017 online","access_note":"Primary abstract text acquired in web search; direct PubMed route returned a cookies challenge. Full article not inspected. Recovery via Europe PMC attempted.","id":"mitral-cleveland-robotic-learning-0","publisher":"Primary journal article","read_at":"2026-10-07","source_type":"Institutional first1000 robotic operations; primary journal abstract plus current official programme body"},"cleveland-valve-center":{"url":"https://my.clevelandclinic.org/departments/heart/depts/mitral-and-tricuspid-valve-center","title":"Mitral and Tricuspid Valve Center","publisher":"Cleveland Clinic"},"cleveland-smedira":{"url":"https://providers.clevelandclinic.org/provider/nicholas-smedira/4268212","title":"Nicholas Smedira — current clinical profile","publisher":"Cleveland Clinic"},"cleveland-robotic-current":{"url":"https://consultqd.clevelandclinic.org/robotically-assisted-mitral-valve-repair-patient-applications-grow","title":"Robotically Assisted Mitral Valve Repair: Patient Applications Grow","publisher":"Cleveland Clinic"},"cleveland-hcm1559":{"url":"https://doi.org/10.1016/j.jtcvs.2018.11.148","title":"Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center","publisher":"Journal of Thoracic and Cardiovascular Surgery"},"cleveland-mitral1000":{"url":"https://pubmed.ncbi.nlm.nih.gov/28893396/","title":"Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases","publisher":"Journal of Thoracic and Cardiovascular Surgery"},"ax-partner3-seven":{"id":"ax-partner3-seven","title":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/","publisher":"New England Journal of Medicine","published":"2025-10-27 online; 2026-02-19 issue","read_at":"2026-10-08","source_type":"Primary randomized trial follow-up","source_kind":"Primary randomized trial follow-up","body_access":"complete_original_abstract_read_via_Europe_PMC","support_location":"Original abstract Methods, Results and Conclusions","doi":"10.1056/NEJMoa2509766","body_file":"sources/partner3.json","access_limit":"NEJM full-text route returned 403. Complete original abstract read via Europe PMC. No device-specific leakage/pacemaker comparison extracted from an unread supplement."},"pd-adult-kapadia-official":{"title":"Samir Kapadia, MD","publisher":"Cleveland Clinic","url":"https://my.clevelandclinic.org/staff/5003-samir-kapadia","read_at":"2026-10-08","kind":"official provider or programme page","support":"Current cardiovascular medicine chair; interventional cardiologist, TAVR and complex coronary intervention expertise.","limitations":"An institutional listing supports current role and stated clinical scope; it does not establish the next appointment, operating allocation or individual risk-adjusted results.","body_file":"outputs/heart-surgery-hub-20261007/review/provider-depth/adult/sources/kapadia-official.txt"},"pd-adult-partner3":{"title":"Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.","publisher":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41144631/","read_at":"2026-10-08","kind":"original study abstract and author/affiliation record","support":"Abstract body and authorship inspected; numerical claims below are restricted to the reported endpoint and population.","limitations":"Full manuscript and supplementary operator allocations were not read in this pass. Authorship is not an individual surgical outcome series.","body_file":"outputs/heart-surgery-hub-20261007/review/provider-depth/adult/sources/partner3.json","published_at":"2025-10-27","doi":"10.1056/nejmoa2509766","authors":"Leon MB, Mack MJ, Pibarot P, Hahn RT, Thourani VH, Kodali SH, Généreux P, Kapadia SR, Cohen DJ, Pocock SJ, Zhang Y, Szerlip M, Ternacle J, Malaisrie SC, Herrmann HC, Szeto WY, Russo MJ, Babaliaros V, Nazif T, Webb JG, Makkar RR, PARTNER 3 Investigators."},"SP13":{"title":"Shinya Unai, MD — cardiac surgery profile","publisher":"Cleveland Clinic","url":"https://providers.clevelandclinic.org/provider/shinya-unai/4268207","read_at":"2026-10-08","source_kind":"official-institution","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/unai-profile.txt","supports":"Current Main Campus surgeon, complex reoperative surgery, endocarditis, aortic/root reconstruction, transplantation and LVAD clinical interests.","limitations":"Hospital and all-surgeon volume/quality statements are not personal procedure-specific results; omitted from candidate."},"SP21":{"title":"The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathologic Challenges.","publisher":"The Annals of thoracic surgery","url":"https://pubmed.ncbi.nlm.nih.gov/41482022/","read_at":"2026-10-08","published_at":"2025-12-31","doi":"10.1016/j.athoracsur.2025.12.007","pmid":"41482022","source_kind":"primary-research-abstract","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/pmid-41482022.json","supports":"Cleveland native aortic valve endocarditis cohort 2002–2020: invasive disease can escape preoperative imaging and require complex reconstruction; Unai coauthor.","limitations":"Historical referral-centre surgical cohort; not all endocarditis patients or personal results."},"SP22":{"title":"Mitral valve abscess: echocardiographic imaging, microbiology, management, and outcomes.","publisher":"European heart journal. Imaging methods and practice","url":"https://pubmed.ncbi.nlm.nih.gov/42394651/","read_at":"2026-10-08","published_at":"2026-07-02","doi":"10.1093/ehjimp/qyag112","pmid":"42394651","source_kind":"primary-research-abstract","local_body":"/Users/eugen/Projects/frankenstein-agentic-framework/outputs/heart-surgery-hub-20261007/review/provider-depth/specialties/sources/pmid-42394651.json","supports":"Cleveland mitral abscess series of 154 adults from databases spanning 2002–2020 and 2010–2020; complex reconstruction and substantial risk; Unai coauthor.","limitations":"Variable follow-up. The 71% total-follow-up mortality is not a fixed-year rate. Programme series, not Unai personal operations; published 2026 does not make cohort current."},"tp-cleveland":{"title":"Cleveland: 1,559 operations in a specialised HCM centre","url":"https://doi.org/10.1016/j.jtcvs.2018.11.148","kind":"primary clinical study; prior research edition","checked":"2026-10-08","accessed":"2026-10-08"},"pc-smedira-current":{"title":"Current official surgeon profile","url":"https://providers.clevelandclinic.org/provider/nicholas-smedira/4268212","kind":"official hospital page","checked":"2026-10-08","accessed":"2026-10-08"},"volume-hcm-nicholas-smedira-participation-over2000":{"id":"volume-hcm-nicholas-smedira-participation-over2000","title":"Dr. Nicholas Smedira, MD - Cleveland, OH - Cardiac Surgery - Request Appointment","url":"https://providers.clevelandclinic.org/provider/nicholas-smedira/4268212","publisher":"Cleveland Clinic","published":null,"read_at":"2026-10-08","source_type":"Reported clinical activity; scope shown with figure"}}}